Portola Pharmaceuticals Inc. (PTLA) Jumps 5.58% on December 23

Equities Staff  |

Portola Pharmaceuticals Inc. (PTLA) was among the biggest gainers on the Russell 2000 for Wednesday December 23 as the stock popped 5.58% to $51.54, representing a gain of $2.725 per share. Some 334,137 shares traded hands on 2,326 trades, compared with an average daily volume of 506,545 shares out of a total float of 52.71 million. The stock opened at $49.13 and traded with an intraday range of $51.88 to $49.00.

After today's gains, Portola Pharmaceuticals Inc. reached a market cap of $2.72 billion. Portola Pharmaceuticals Inc. has had a trading range between $57.96 and $26.26 over the last year, and it had a 50-day SMA of $48.74 and a 200-day SMA of $45.07.

Portola Pharmaceuticals Inc is a biopharmaceutical company. It develops & commercializes novel therapeutics in the areas of thrombosis, other hematologic disorders & inflammation for patients who currently have limited or no approved treatment options.

Portola Pharmaceuticals Inc. is based out of South San Francisco, CA and has some 70 employees. Its CEO is William Lis.

For a complete fundamental analysis analysis of Portola Pharmaceuticals Inc., check out Equities.com’s Stock Valuation Analysis report for PTLA. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Goldrea Resources Corp.

Goldrea Resources Corp is engaged in the acquisition, exploration and development of mineral properties located in North America.